News archive

Home News archivePage 5

ADIENNE Pharma & Biotech: A Success Story in Innovation

January 18, 2025 By Editorial Staff In Technologies
Antonio Francesco Di Naro
An Interview with Antonio Francesco Di Naro for the C Suite Feature of Sanità33, by Ludovico Baldessin From pioneering single-use technologies for manufacturing biological drugs to achieving a global patent leadership in preparing cytotoxic drugs by lyophilizing them directly in ready-to-use multi-...
Read More

ReChb: An Ancestral CRISPR–Cas12a variant with flexible applications

January 18, 2025 By Editorial Staff In R&D
Ancestral sequence reconstruction has led to the discovery and synthesis of ReChb, a revolutionary variant of CRISPR–Cas12a with remarkable versatility. ReChb’s ability to target any nucleic acid with minimal constraints positions it as a transformative tool for genome editing and genetic diagno...
Read More

Gut Revolution: Fecal Transplants vs. Live Biotherapeutic Products

January 18, 2025 By Editorial Staff In R&D
An article published in Gut Microbes (2024) introduces a groundbreaking class of drugs known as Live Biotherapeutic Products (LBPs), which are making waves in the biotechnology world. These “super bugs” are based on live microorganisms—such as bacteria, viruses, and fungi—engineered ...
Read More

Biotech: Angelini Ventures Leads €20 Million Financing Round for NeumirnaNeumirna Therapeutics: Pioneering RNA-Based Therapies for Neurological Disorders

January 18, 2025 By Editorial Staff In Startup, Technologies
Angelini Ventures Leads €20 Million Financing Round for Neumirna Neumirna Therapeutics Pioneering RNA-Based Therapies for Neurological Disorders
Neumirna Therapeutics, a Danish biotechnology company specializing in RNA-based therapies for next-generation treatments of neurological disorders, has announced the first closing of its €20 million Series A financing round. The investment was co-led by new investors Angelini Ventures and Invivo P...
Read More

ENEA-Tech and Biomedical Foundation: Investment in Innovative Radiotherapy Project for the Treatment of Inoperable Solid Tumors

January 18, 2025 By Editorial Staff In R&D, Uncategorized
enea medtech Towards the Future of Cancer Care
The ENEA-Tech and Biomedical Foundation has announced a significant strategic investment of €6 million in BetaGlue Therapeutics S.p.A., an Italian company at the forefront of oncology. Supporting a Revolutionary Technology for Precision MedicineThe investment aims to support the development of an ...
Read More